MRX Investor Alert: Class‑Action Lawsuit Filed Against Marex Group plc

A U.S. law firm, Bronstein, Gewirtz & Grossman, LLC (BG&G), announced on November 28, 2025 that a class‑action lawsuit has been filed against Marex Group plc (NASDAQ: MRX) and certain of its officers — and is inviting investors who suffered substantial losses to step forward. The lawsuit covers all individuals and entities that purchased or acquired Marex securities between May 16, 2024 and August 5, 2025 (the “Class Period”). According to the complaint, during that period Marex allegedly: Sold over‑the‑counter (OTC) financial products to itself, creating undisclosed conflicts of interest; Recorded significant inconsistencies between its subsidiaries and related parties, thereby rendering its financial statements unreliable; Misleadingly represented the company’s business, operations, and financial health — so once the truth emerged, investors sustained losses. If you were a Marex investor who lost money during the Class Period, you may be eligible to join the class action. BG&G states there is no cost to participate — the firm works on a contingency‑fee basis and is only paid fees if the case succeeds. Interested investors must request to be named lead plaintiff by December 8, 2025. Even if you don’t serve as lead plaintiff, you can still share in potential recovery. #MarexGroup #MRX #ClassAction #InvestorAlert #SlimScan #GrowthStocks #CANSLIM